Consultant for Cellectar (NASDAQ: CLRB) receives grant of 15,000 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cellectar Biosciences, Inc. reported that consultant Loren Stefan received a grant of stock options. The award covers 15,000 stock options with an exercise price of $2.6800 per share, expiring on July 8, 2036. These options relate to 15,000 shares of common stock and will vest in full on July 8, 2027, subject to continued service. Following this grant, Stefan holds 15,000 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Loren Stefan
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 15,000 | $0.00 | -- |
Holdings After Transaction:
Stock option (right to buy) — 15,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 15,000 options
Exercise price: $2.6800 per share
Underlying shares: 15,000 shares
+2 more
5 metrics
Options granted
15,000 options
Stock option grant to consultant Loren Stefan
Exercise price
$2.6800 per share
Strike price for granted stock options
Underlying shares
15,000 shares
Common stock underlying the options
Expiration date
July 8, 2036
Option expiration for this grant
Post-transaction derivative holdings
15,000 options
Total derivative securities held after grant
Key Terms
Stock option (right to buy), Grant, award, or other acquisition, exercise price, vesting
4 terms
Stock option (right to buy) financial
"security_title: Stock option (right to buy)"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price: 2.6800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"This option shall vest in full on July 8, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transaction did Cellectar Biosciences (CLRB) report for Loren Stefan?
Cellectar Biosciences reported that consultant Loren Stefan received a grant of 15,000 stock options. The options give the right to buy common shares at a set price and represent compensation rather than an open-market share purchase or sale.
How many Cellectar Biosciences (CLRB) options were granted to Loren Stefan and at what price?
Loren Stefan was granted 15,000 stock options with an exercise price of $2.6800 per share. Each option relates to one share of Cellectar common stock, providing potential future equity exposure if exercised at or above the strike price.
When do Loren Stefan’s CLRB stock options vest and when do they expire?
The 15,000 Cellectar stock options granted to Loren Stefan vest in full on July 8, 2027. They carry an expiration date of July 8, 2036, giving a multi-year window after vesting to decide whether to exercise the options.
What is Loren Stefan’s reported Cellectar (CLRB) derivative holdings after this option grant?
After the transaction, Loren Stefan is reported to hold 15,000 derivative securities, all from this option grant. These are held directly and represent rights to acquire common shares at the fixed exercise price if exercised in the future.